KPC Pharmaceuticals Inc banner

Intrinsic Value

The intrinsic value of KPC Pharmaceuticals Inc (600422) under the Base Case is 9.82 CNY per share. Compared with the current market price of 8.47 CNY, the stock appears Undervalued by 14% .

The intrinsic value is calculated using the DCF method. The model mostly extends the recent record: revenue grows about -2% a year over the next five years, against -3% over the last five, and net margin stays near last year's 5.3%. If revenue grew at its five-year pace of -3%, the estimate would be about ¥6.54.

Do our valuations actually work? See backtest results .

Intrinsic Value
¥9.82
Undervaluation 14%
Intrinsic Value
Price ¥8.47
Alert me when KPC Pharmaceuticals Inc is below its intrinsic value
Today ¥7.85 · 7.3% below the current price

KPC Pharmaceuticals Inc is cheaper than usual. It was this cheap or cheaper on just 24% of days in the past 5 years.

Alternatives to KPC Pharmaceuticals Inc

Fundamental Analysis

What KPC Pharmaceuticals Does

Pharmaceuticals Health Care

KPC Pharmaceuticals makes and sells medicines in China, with a strong focus on traditional Chinese medicine products along with some chemical drugs and related healthcare products. It develops, manufactures, and markets prescription medicines and over-the-counter products used for common conditions such as infections, pain, and cardiovascular or respiratory care. Its business is built around finished drug products rather than raw materials alone.

Headquarters
China CN
Employees
5 072
IPO date
Dec 6, 2000
Read the full company overview
View Company Overview

KPC Pharmaceuticals has no economic moat

No Moat Narrow Wide

KPC Pharmaceuticals Inc lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.

Read the full moat analysis
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Continue Research

Decided on KPC Pharmaceuticals? Get an email when KPC Pharmaceuticals Inc reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one KPC Pharmaceuticals Inc stock?

The intrinsic value for KPC Pharmaceuticals Inc (600422) under the Base Case is 9.82 CNY.

Is KPC Pharmaceuticals Inc stock undervalued or overvalued?

Compared with the current market price of 8.47 CNY, the stock appears Undervalued by 14% .

How reliable are our estimates? See how past valuations played out
Back to Top